672 GENES FOUNDi
Show / hide columns XML | RDF | TSV | « prev | Page of 14 | next »
Genei Gene descriptioni x Protein classi x Tissue Cell Pathology Subcellular locationi x RNA tissue categoryi x
POLE3DNA polymerase epsilon 3, accessory subunitEnzymes
FDA approved drug targets
Predicted intracellular proteins
Nucleus
Nucleoli
Expressed in all
POLE4DNA polymerase epsilon 4, accessory subunitEnzymes
FDA approved drug targets
Predicted intracellular proteins
Nucleus
Cytosol
Expressed in all
PPARAPeroxisome proliferator activated receptor alphaFDA approved drug targets
Nuclear receptors
Predicted intracellular proteins
Transcription factors
NucleusExpressed in all
PPARDPeroxisome proliferator activated receptor deltaFDA approved drug targets
Nuclear receptors
Predicted intracellular proteins
Transcription factors
Expressed in all
PPARGPeroxisome proliferator activated receptor gammaCancer-related genes
Disease related genes
FDA approved drug targets
Nuclear receptors
Plasma proteins
Predicted intracellular proteins
Transcription factors
Nucleus
Vesicles
Tissue enhanced
PPP3R2Protein phosphatase 3 regulatory subunit B, betaFDA approved drug targets
Predicted intracellular proteins
Plasma membrane
Cytosol
Tissue enriched
PRDX5Peroxiredoxin 5Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Mitochondria
Cytosol
Expressed in all
PRKAA1Protein kinase AMP-activated catalytic subunit alpha 1Enzymes
FDA approved drug targets
Predicted intracellular proteins
Nuclear specklesExpressed in all
PRKAB1Protein kinase AMP-activated non-catalytic subunit beta 1FDA approved drug targets
Predicted intracellular proteins
Nucleoplasm
Cytosol
Expressed in all
PRLRProlactin receptorDisease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
PROCProtein C, inactivator of coagulation factors Va and VIIIaCancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Tissue enriched
PROS1Protein S (alpha)Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
PSMB1Proteasome subunit beta 1Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
NucleusExpressed in all
PSMB10Proteasome subunit beta 10Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
CytosolExpressed in all
PSMB2Proteasome subunit beta 2Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
NucleoplasmExpressed in all
PSMB5Proteasome subunit beta 5Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Nucleus
Centrosome
Expressed in all
PSMB8Proteasome subunit beta 8Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Vesicles
Cytokinetic bridge
Mixed
PSMB9Proteasome subunit beta 9Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
CytosolMixed
PTGER1Prostaglandin E receptor 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhanced
PTGER2Prostaglandin E receptor 2FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Mixed
PTGER3Prostaglandin E receptor 3FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Group enriched
PTGER4Prostaglandin E receptor 4FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Expressed in all
PTGFRProstaglandin F receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
PTGIRProstaglandin I2 (prostacyclin) receptor (IP)FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
PTGISProstaglandin I2 synthaseDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Endoplasmic reticulumMixed
PTGS1Prostaglandin-endoperoxide synthase 1Cancer-related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted secreted proteins
Golgi apparatus
Vesicles
Tissue enhanced
PTGS2Prostaglandin-endoperoxide synthase 2Cancer-related genes
Enzymes
FDA approved drug targets
Predicted secreted proteins
Endoplasmic reticulumTissue enhanced
PTH2RParathyroid hormone 2 receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Mixed
QPRTQuinolinate phosphoribosyltransferaseEnzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Expressed in all
RAF1Raf-1 proto-oncogene, serine/threonine kinaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
RAS pathway related proteins
Nuclear specklesExpressed in all
RAMP1Receptor activity modifying protein 1FDA approved drug targets
Predicted membrane proteins
Nucleoplasm
Nuclear membrane
Tissue enhanced
RAMP2Receptor activity modifying protein 2FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
VesiclesMixed
RAMP3Receptor activity modifying protein 3FDA approved drug targets
Predicted membrane proteins
Tissue enhanced
RARARetinoic acid receptor alphaCancer-related genes
Disease related genes
FDA approved drug targets
Nuclear receptors
Plasma proteins
Predicted intracellular proteins
Transcription factors
Nucleus
Cytosol
Expressed in all
RARBRetinoic acid receptor betaCancer-related genes
Disease related genes
FDA approved drug targets
Nuclear receptors
Predicted intracellular proteins
Transcription factors
NucleoplasmMixed
RARGRetinoic acid receptor gammaCancer-related genes
FDA approved drug targets
Nuclear receptors
Plasma proteins
Predicted intracellular proteins
Transcription factors
NucleoplasmTissue enhanced
RENReninCandidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted secreted proteins
Tissue enhanced
RETRet proto-oncogeneCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Vesicles
Plasma membrane
Cytosol
Tissue enriched
RFKRiboflavin kinaseEnzymes
FDA approved drug targets
Predicted intracellular proteins
Golgi apparatusExpressed in all
RPL3Ribosomal protein L3FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Ribosomal proteins
Nucleoli
Cytosol
Expressed in all
RRM1Ribonucleotide reductase catalytic subunit M1Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
CytosolExpressed in all
RRM2Ribonucleotide reductase regulatory subunit M2Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
CytosolMixed
RRM2BRibonucleotide reductase regulatory TP53 inducible subunit M2BDisease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Nucleoplasm
Cytosol
Expressed in all
RXRARetinoid X receptor alphaCancer-related genes
FDA approved drug targets
Nuclear receptors
Predicted intracellular proteins
Transcription factors
Nucleus
Golgi apparatus
Mixed
RXRBRetinoid X receptor betaCancer-related genes
FDA approved drug targets
Nuclear receptors
Predicted intracellular proteins
Transcription factors
NucleusMixed
RXRGRetinoid X receptor gammaCancer-related genes
FDA approved drug targets
Nuclear receptors
Plasma proteins
Predicted intracellular proteins
Transcription factors
Nucleoplasm
Nuclear bodies
Tissue enhanced
RYR1Ryanodine receptor 1Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Golgi apparatus
Vesicles
Cytosol
Tissue enriched
RYR2Ryanodine receptor 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Nucleoplasm
Plasma membrane
Cytosol
Tissue enriched
S1PR1Sphingosine-1-phosphate receptor 1Cancer-related genes
CD markers
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
VesiclesExpressed in all
S1PR5Sphingosine-1-phosphate receptor 5FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
« prev | Page of 14 | next »